Replimune Newsroom

Analysts Are Bullish on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Replimune Group (REPL)

TipRanksDec 5 10:23 ET

Jefferies Maintains Buy on Replimune Group, Raises Price Target to $19

BenzingaDec 4 02:54 ET

Replimune Group Analyst Ratings

BenzingaDec 4 02:52 ET

BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $18

Moomoo NewsNov 22 07:33 ET

Replimune Group Analyst Ratings

BenzingaNov 22 07:01 ET

H.C. Wainwright Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17

Moomoo NewsNov 22 06:32 ET

J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Cuts Target Price to $16

Moomoo NewsNov 21 07:32 ET

BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsNov 13 07:31 ET

Barclays Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17

Moomoo NewsNov 13 05:38 ET

H.C. Wainwright Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17

Moomoo NewsNov 12 11:32 ET

Replimune Group Analyst Ratings

BenzingaNov 12 11:24 ET

Replimune Group Is Maintained at Overweight by JP Morgan

Dow JonesSep 24 10:05 ET

J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $17

Moomoo NewsSep 24 07:33 ET

Jefferies Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsSep 18 09:32 ET

Jefferies Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $16

Moomoo NewsSep 18 08:32 ET

Replimune Group Analyst Ratings

BenzingaSep 16 06:54 ET

H.C. Wainwright Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17

Moomoo NewsSep 16 06:31 ET

Barclays Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17

Moomoo NewsSep 16 03:31 ET

BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsSep 10 07:31 ET

H.C. Wainwright Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17

Moomoo NewsSep 10 06:31 ET